Guides, research, and insights from Compare Telehealth Providers — Honest Reviews
14 articlesThe FDA proposes permanently excluding semaglutide, tirzepatide, and liraglutide from 503B bulk compounding. Comment period closes June 29, 2026.
775+ adverse events from compounded GLP-1. Here's how to tell if your telehealth provider is legitimate — and when to walk away.
Eli Lilly's triple-hormone drug is the most effective weight loss medication ever tested. It's also 2+ years away. Here's why starting now is smarter.
Two GLP-1 pills, very different rules. We compare orforglipron (Foundayo) and oral Wegovy on dosing, efficacy, convenience, and pricing.
May 2026 NIH study: oral GLP-1 pills suppress eating for pleasure via deep brain pathways. Different mechanism than injectables.
CMS launches $50/mo GLP-1 access for Medicare July 2026. We read every line of the announcement so you don't have to.
Most sites show starting prices. We show what you'll actually pay at maintenance dose. Complete GLP-1 pricing at every titration step.
Prices dropped, pills launched, Medicare joined. The competitive landscape for GLP-1 medications has never been more favorable for patients.
The April 30, 2026 FDA proposal to remove GLP-1s from the 503B Bulks List. We break down who benefits, who loses, and what it means for your medication.
Compounded GLP-1 costs 50-80% less than brand. But is it the same medication? We compare cost, safety, legality, and efficacy with actual numbers.
75-80% weight maintenance sounds good. But what about the 20-25% you lose? We analyze the ATTAIN-MAINTAIN data honestly.
Compounded GLP-1s cost 60-80% less but aren't FDA-approved. Brand-name versions have clinical trial backing. Here's how to choose.
New real-world data from ASCO 2026 shows GLP-1 medications may reduce metastatic progression in lung, breast, colorectal, and liver cancers.
What to expect in your first 30 days on semaglutide or tirzepatide — from side effects to appetite changes to your first weigh-in.
No articles found matching your search.